Budget impact of tegaserod on a managed care organization formulary.

The American journal of managed care

Volumn 11, Issue 1 Suppl, 2005, Pages

  Bloom, Michael A ^a   Barghout, Victoria ^a   Kahler, Kristijan H ^a   Bentkover, Judith ^a   Kurth, Hannah ^a   Gralnek, Ian M ^a   Spiegel, Brennan M R ^a  

^a Innovative Health Solutions   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL AGENT; INDOLE DERIVATIVE; SEROTONIN AGONIST; TEGASEROD;

ADULT; ARTICLE; BUDGET; CONSTIPATION; COST OF ILLNESS; DRUG COST; ECONOMICS; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; IRRITABLE COLON; LONGITUDINAL STUDY; MIDDLE AGED; PRESCRIPTION; PUBLICATION; RETROSPECTIVE STUDY; STATISTICAL MODEL; UNITED STATES; UTILIZATION REVIEW;

ADULT; BUDGETS; CONSTIPATION; COST OF ILLNESS; DRUG COSTS; FEMALE; FORMULARIES; GASTROINTESTINAL AGENTS; HEALTH CARE COSTS; HUMANS; INDOLES; IRRITABLE BOWEL SYNDROME; LONGITUDINAL STUDIES; MANAGED CARE PROGRAMS; MIDDLE AGED; MODELS, STATISTICAL; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; SEROTONIN AGONISTS; UNITED STATES; UTILIZATION REVIEW;

EID: 19844367329     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)